Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Item
http://www.wikidata.org/entity/Q37440864
Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.Estrogen and ERalpha: culprits in cervical cancer?Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancyDouble-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer preventionChemoprevention of lung tumorigenesis by intranasally administered diindolylmethane in A/J mice.Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.Normal human immune cells are sensitive to telomerase inhibition by Brassica-derived 3,3-diindolylmethane,partly mediated via ERα/β-AP1 signaling.Pharmacokinetics and pharmacodynamics of 3,3'-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes.DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy
P2860

Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Item
http://www.wikidata.org/entity/Q37440864
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@en
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@nl
type
label
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@en
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@nl
prefLabel
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@en
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Diindolylmethane inhibits cerv ...... -HPV16 transgenic mouse model.
@en
P2093
P2860
P304
P31
P356
10.1158/1055-9965.EPI-09-0698
P433
P478
P50
P577
P698
P932